Literature DB >> 15572050

Novel C-terminus frameshift mutation, 1122fs/147, of HERG in LQT2: additional amino acids generated by frameshift cause accelerated inactivation.

Tetsuo Sasano1, Kazuo Ueda, Minako Orikabe, Yuji Hirano, Seiko Kawano, Michio Yasunami, Mitsuaki Isobe, Akinori Kimura, Masayasu Hiraoka.   

Abstract

OBJECTIVE: The function of the C-terminus region of the human ether-a-go-go related gene (HERG) has not been well characterized except for its involvement in trafficking. To understand further the role of C-terminus region, we performed a functional analysis of a novel frameshift mutation (1122fs/147) identified in a Japanese long QT syndrome 2 (LQT2) patient who had recurrent episodes of syncope.
METHODS: Wild type (WT) and mutant HERG plasmids were transfected into human embryonic kidney (HEK-293) cells, and whole-cell current was recorded by the patch-clamp technique. Confocal microscopy was performed to examine the membrane distribution of channel protein using a green fluorescent protein tagged to the N-terminus of HERG.
RESULTS: The mutant 1122fs/147 alone could express current, but reduced density by 74% of control. No dominant negative effect was noted with co-expression of WT and 1122fs/147. Activation and deactivation time constants were not changed, while inactivation was accelerated in 1122fs/147 compared to WT, and V(1/2) of steady-state inactivation curve shifted by 11 mV in the negative direction. Current density of 1123stop mutant revealed 49% reduction compared to WT and showed no shift in steady-state inactivation. Confocal microscopy revealed reduced protein expression on the cell surface both in 1122fs/147 and 1123stop mutants compared to WT.
CONCLUSION: Frameshift mutation at the C-terminus region with additional 147 amino acids evoked a loss of function of the HERG channel. A negative shift in steady-state inactivation induced by the additional 147 amino acids and trafficking defect contribute to a reduced current amplitude of 1122fs/147.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15572050     DOI: 10.1016/j.yjmcc.2004.09.010

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  7 in total

Review 1.  Emerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking.

Authors:  William T Harkcom; Geoffrey W Abbott
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-08

2.  Synergic effects of β-estradiol and erythromycin on hERG currents.

Authors:  Fumiaki Ando; Akinori Kuruma; Seiko Kawano
Journal:  J Membr Biol       Date:  2011-04-12       Impact factor: 1.843

Review 3.  Molecular Pathophysiology of Congenital Long QT Syndrome.

Authors:  M S Bohnen; G Peng; S H Robey; C Terrenoire; V Iyer; K J Sampson; R S Kass
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

4.  A new C-terminal hERG mutation A915fs+47X associated with symptomatic LQT2 and auditory-trigger syncope.

Authors:  Georges Christé; Olivier Thériault; Mohamed Chahine; Gilles Millat; Claire Rodriguez-Lafrasse; Robert Rousson; Isabelle Deschênes; Eckhard Ficker; Philippe Chevalier
Journal:  Heart Rhythm       Date:  2008-08-31       Impact factor: 6.343

5.  Electrophysiological and fluorescence microscopy studies with HERG channel/EGFP fusion proteins.

Authors:  Sonja Claassen; Sarah Schwarzer; Jost Ludwig; Bernd J Zünkler
Journal:  J Membr Biol       Date:  2008-03       Impact factor: 1.843

6.  Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation.

Authors:  Anton Mihic; Vijay S Chauhan; Xiaodong Gao; Gavin Y Oudit; Robert G Tsushima
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

7.  Multiple mechanisms underlie reduced potassium conductance in the p.T1019PfsX38 variant of hERG.

Authors:  Majid K Al Salmani; Rezvan Tavakoli; Wajid Zaman; Ahmed Al Harrasi
Journal:  Physiol Rep       Date:  2022-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.